Therapeutic approaches to systemic sclerosis: recent approvals and future candidate therapies

A Lescoat, D Roofeh, M Kuwana, R Lafyatis… - Clinical reviews in …, 2023 - Springer
Systemic sclerosis is the rheumatic disease with the highest individual mortality. The severity
of the disease is determined by the extent of fibrotic changes to cutaneous and internal …

New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine

A Lescoat, J Varga, M Matucci-Cerinic… - Expert opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Systemic sclerosis (SSc), also known as scleroderma, is a complex
orphan disease characterized by early inflammatory features, vascular hyper-reactivity, and …

Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype

X Bao, X Liu, N Liu, S Zhuang, Q Yang, H Ren… - Respiratory …, 2021 - Springer
Background We recently reported histone methyltransferase enhancer of zeste homolog 2
(EZH2) as a key epigenetic regulator that contributes to the dysfunction of innate immune …

Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts

Y Takenouchi, K Kitakaze, K Tsuboi… - Experimental cell research, 2020 - Elsevier
Lung fibrosis is a devastating disease characterized by fibroblast accumulation and
extracellular matrix deposition in lungs. However, its molecular and cellular pathogenesis is …

Involvement of 4-hydroxy-2-nonenal in the pathogenesis of pulmonary fibrosis

E Reyes-Jiménez, AA Ramírez-Hernández… - Molecular and Cellular …, 2021 - Springer
Pulmonary fibrosis is a chronic progressive disease with high incidence, prevalence, and
mortality rates worldwide. It is characterized by excessive accumulation of extracellular …

Neuropilin 1 modulates TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer

Z Ding, W Du, Z Lei, Y Zhang… - International …, 2019 - spandidos-publications.com
Previously, the authors reported that neuropilin-1 (NRP1) was significantly increased and
acted as a vital promoter in the metastasis of non-small cell lung cancer (NSCLC). However …

The promising therapeutic approaches for radiation-induced pulmonary fibrosis: targeting radiation-induced mesenchymal transition of alveolar type II epithelial cells

P Wang, Z Yan, PK Zhou, Y Gu - International Journal of Molecular …, 2022 - mdpi.com
Radiation-induced pulmonary fibrosis (RIPF) is a common consequence of radiation for
thoracic tumors, and is accompanied by gradual and irreversible organ failure. This severely …

SIgA in various pulmonary diseases

X Wang, J Zhang, Y Wu, Y Xu, J Zheng - European Journal of Medical …, 2023 - Springer
Secretory immunoglobulin A (SIgA) is one of the most abundant immunoglobulin subtypes
among mucosa, which plays an indispensable role in the first-line protection against …

Tranilast inhibits pulmonary fibrosis by suppressing TGFβ/SMAD2 pathway

M Kato, F Takahashi, T Sato, Y Mitsuishi… - Drug Design …, 2020 - Taylor & Francis
Purpose Idiopathic pulmonary fibrosis (IPF) is characterized by the accumulation of
extracellular matrix (ECM) protein in the lungs. Transforming growth factor (TGF) β-induced …

An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

G Manzotti, F Torricelli, D Benedetta, F Lococo… - Clinical Cancer …, 2019 - AACR
Purpose: Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive form of NSCLC.
Rarity and poor characterization have limited the development of PSC-tailored treatment …